Running Your Business
|
March 8, 2023

Bile Acids 101: Testing, Interpreting, Treatment

Medically Reviewed by
Updated On
September 17, 2024

Bile acids are a family of cholesterol-derived molecules made and secreted by the liver into the small intestine to support the digestion and absorption of fats. This article will discuss the symptoms and conditions associated with imbalances in bile acid metabolism and the therapeutic indications for bile acids in the functional medicine setting.

[signup]

What are Bile Acids?

Bile acids are steroid acids found predominantly in bile, synthesized in the liver as end products of cholesterol metabolism. They are responsible for fat emulsification, aiding fat digestion and absorption in the small intestine. Additionally, bile salts help the body absorb fat-soluble vitamins A, D, E, and K. (1, 2)

Primary bile acids, chenodeoxycholic acid (CDCA), and cholic acid (CA) are derived from cholesterol in the liver. Liver cells then conjugate them by adding a glycine or taurine residue to form conjugated bile acids (or bile salts). Bile salts are secreted into the small intestine to aid fat digestion and absorption and travel to the large intestine. In the large intestine, commensal gut bacteria modify the bile salts by removing the glycine and taurine groups. This results in the formation of secondary bile acids, where CDCA is converted to lithocholic acid (LCA) and CA is converted to deoxycholic acid (DCA). Clostridium, Enterococcus, Bacteroides, and Lactobacillus bacteria are primarily responsible for deconjugating bile salts into secondary bile acids. All four bile acids can be absorbed by intestinal cells and recycled back to the liver. (1, 2)

Clinical Significance of Elevated Bile Acids

Emerging evidence supports the notion that elevated primary bile acids and their interactions with intestinal and immune cells contribute to the inflammatory process underlying inflammatory bowel disease (IBD) development and progression (8).

Elevated secondary bile acids have been associated with the following:

  • Impaired gallbladder function and cholesterol gallstone formation (3, 4)
  • Large intestinal inflammation, which contributes to a compromised gut barrier and increased intestinal permeability (5, 6)
  • Colon cancer, especially with an elevated LCA:DCA ratio. Secondary bile acids have been associated with increased DNA damage and have been shown to have carcinogenic properties. LCA is thought to be more toxic than DCA due to its inhibitory effects on antioxidant pathways. (7)

Bile acid diarrhea (BAD) causes up to 33% of chronic diarrhea. Poor bile acid reabsorption in the small intestine and excessive bile acid concentrations in the colon lead to increased colonic motility and secretions, causing diarrhea, fecal urgency, and abdominal cramping.

Clinical Significance of Low Bile Acids

When bile acid production is insufficient, fat-soluble vitamins and fatty acids will be poorly absorbed, leading to nutrient deficiencies over time. Additionally, when these unabsorbed fatty nutrients travel to the colon, they can cause digestive symptoms like diarrhea, gas, and abdominal cramping.

Bile acids act as steroid hormones, having various direct metabolic actions in the body. Deficient bile salts can disrupt normal hormone synthesis and negatively impact metabolic function, contributing to elevated triglycerides, blood sugar, and fatty liver disease.

Bile supersaturated with cholesterol due to low concentration of bile acids is a primary cause of cholesterol gallstones.

Low secondary bile acids may result from the use of broad-spectrum antibiotics, causing intestinal dysbiosis, and reduced cholesterol intake or absorption.

Functional Medicine Labs to Test for Bile Acids

Bile acids can be measured through blood and stool samples. Blood testing is typically indicated for the assessment of liver and gallbladder health. Comprehensive stool testing also allows for an extensive evaluation of fat malabsorption, intestinal inflammation, and dysbiotic patterns of the intestinal microbiome, often accompanying bile acid imbalances.

For patients at increased risk for diabetes, liver disease, and gallstones, a comprehensive metabolic panel (CMP) can monitor blood sugar and liver/gallbladder function.

A cholesterol panel can diagnose high or low cholesterol contributing to abnormal bile acid levels. This Cholesterol Balance test can provide additional insight into the cause of abnormal cholesterol levels by measuring markers of endogenous synthesis and gastrointestinal absorption of cholesterol.

A nutrient panel can measure micronutrients and identify deficiencies if fat malabsorption is suspected.

Bile Acids in Functional Medicine Protocols

For those with bile acid imbalances, diet can significantly impact the gastrointestinal metabolism and regulation of bile acid levels. Resistant starch and insoluble fiber in the diet can reduce secondary bile acids in the stool by binding to them and increasing fecal elimination. Insoluble fiber also promotes short chain fatty acid production in the colon, lowering intestinal pH and inhibiting the enzyme that deconjugates bile salts, thereby reducing concentrations of LCA and DCA. High consumption of saturated fats and red meat is, conversely, associated with elevated secondary bile acid levels. (9, 10)

Bile acids and their derivatives can be used therapeutically and benefit human health in various scenarios.

  • Ursodeoxycholic acid (UDCA) and/or CDCA are commonly prescribed to dissolve gallstones (11).
  • UDCA has been proven to be especially beneficial in treating cholestatic liver diseases, including primary biliary cirrhosis, pediatric cholestatic disorders, primary sclerosing cholangitis, and drug-induced cholestasis (12).
  • Some cases of bile reflux, backflow of bile from the small intestine into the stomach and esophagus, can be treated with UDCA.
  • Promising emerging evidence suggests that bile acid treatment can downregulate inflammation associated with psoriasis.
  • CA is approved for treating rare bile acid synthesis disorders (13, 14).
  • A growing body of evidence supports the beneficial effects of tauroursodeoxycholic acid (TUDCA) in fat digestion, microbiome diversity, reduction of cellular stress, liver disease, and neurological concerns.

Summary

Bile acids support fat digestion, stimulate bile flow, and enhance cholesterol elimination. Imbalances in bile acid synthesis and metabolism are associated with fat malabsorption, nutrient deficiencies, and metabolic diseases like diabetes. Blood and stool tests can evaluate bile acid levels and ratios to determine underlying causes of digestive and metabolic symptoms. Addressing diet and the microbiome can support healthy bile acid levels. Emerging evidence supports a wide range of therapeutic uses for bile acids/salts. Working with a functional medicine doctor, you can learn how bile acids may affect your health and if you are a good candidate for bile acid supplementation.

Bile acids are a family of cholesterol-derived molecules made and secreted by the liver into the small intestine to support the digestion and absorption of fats. This article will discuss the symptoms and conditions associated with imbalances in bile acid metabolism and the potential roles of bile acids in supporting health within the functional medicine setting.

[signup]

What are Bile Acids?

Bile acids are steroid acids found predominantly in bile, synthesized in the liver as end products of cholesterol metabolism. They are responsible for fat emulsification, aiding fat digestion and absorption in the small intestine. Additionally, bile salts help the body absorb fat-soluble vitamins A, D, E, and K. (1, 2)

Primary bile acids, chenodeoxycholic acid (CDCA), and cholic acid (CA) are derived from cholesterol in the liver. Liver cells then conjugate them by adding a glycine or taurine residue to form conjugated bile acids (or bile salts). Bile salts are secreted into the small intestine to aid fat digestion and absorption and travel to the large intestine. In the large intestine, commensal gut bacteria modify the bile salts by removing the glycine and taurine groups. This results in the formation of secondary bile acids, where CDCA is converted to lithocholic acid (LCA) and CA is converted to deoxycholic acid (DCA). Clostridium, Enterococcus, Bacteroides, and Lactobacillus bacteria are primarily responsible for deconjugating bile salts into secondary bile acids. All four bile acids can be absorbed by intestinal cells and recycled back to the liver. (1, 2)

Clinical Significance of Elevated Bile Acids

Emerging evidence suggests that elevated primary bile acids and their interactions with intestinal and immune cells may contribute to the inflammatory processes associated with inflammatory bowel conditions (8).

Elevated secondary bile acids have been associated with the following:

  • Impaired gallbladder function and cholesterol gallstone formation (3, 4)
  • Large intestinal inflammation, which may contribute to a compromised gut barrier and increased intestinal permeability (5, 6)
  • Colon health concerns, especially with an elevated LCA:DCA ratio. Secondary bile acids have been associated with increased DNA damage and have been shown to have properties that may affect cellular health. LCA is thought to be more toxic than DCA due to its inhibitory effects on antioxidant pathways. (7)

Bile acid diarrhea (BAD) may contribute to up to 33% of chronic diarrhea cases. Poor bile acid reabsorption in the small intestine and excessive bile acid concentrations in the colon can lead to increased colonic motility and secretions, potentially causing diarrhea, fecal urgency, and abdominal cramping.

Clinical Significance of Low Bile Acids

When bile acid production is insufficient, fat-soluble vitamins and fatty acids may be poorly absorbed, potentially leading to nutrient deficiencies over time. Additionally, when these unabsorbed fatty nutrients travel to the colon, they can cause digestive symptoms like diarrhea, gas, and abdominal cramping.

Bile acids act as steroid hormones, having various direct metabolic actions in the body. Deficient bile salts can disrupt normal hormone synthesis and negatively impact metabolic function, potentially contributing to elevated triglycerides, blood sugar, and fatty liver concerns.

Bile supersaturated with cholesterol due to low concentration of bile acids is a primary cause of cholesterol gallstones.

Low secondary bile acids may result from the use of broad-spectrum antibiotics, causing intestinal dysbiosis, and reduced cholesterol intake or absorption.

Functional Medicine Labs to Test for Bile Acids

Bile acids can be measured through blood and stool samples. Blood testing is typically indicated for the assessment of liver and gallbladder health. Comprehensive stool testing also allows for an extensive evaluation of fat malabsorption, intestinal inflammation, and dysbiotic patterns of the intestinal microbiome, often accompanying bile acid imbalances.

For individuals at increased risk for diabetes, liver concerns, and gallstones, a comprehensive metabolic panel (CMP) can monitor blood sugar and liver/gallbladder function.

A cholesterol panel can help assess cholesterol levels that may contribute to abnormal bile acid levels. This Cholesterol Balance test can provide additional insight into the cause of abnormal cholesterol levels by measuring markers of endogenous synthesis and gastrointestinal absorption of cholesterol.

A nutrient panel can measure micronutrients and identify deficiencies if fat malabsorption is suspected.

Bile Acids in Functional Medicine Protocols

For those with bile acid imbalances, diet can significantly impact the gastrointestinal metabolism and regulation of bile acid levels. Resistant starch and insoluble fiber in the diet may help reduce secondary bile acids in the stool by binding to them and increasing fecal elimination. Insoluble fiber also promotes short chain fatty acid production in the colon, which may lower intestinal pH and inhibit the enzyme that deconjugates bile salts, thereby potentially reducing concentrations of LCA and DCA. High consumption of saturated fats and red meat is, conversely, associated with elevated secondary bile acid levels. (9, 10)

Bile acids and their derivatives may be used in various scenarios to support health.

  • Ursodeoxycholic acid (UDCA) and/or CDCA are commonly prescribed to help manage gallstones (11).
  • UDCA has been shown to be beneficial in supporting liver health in conditions like primary biliary cirrhosis, pediatric cholestatic disorders, primary sclerosing cholangitis, and drug-induced cholestasis (12).
  • Some cases of bile reflux, backflow of bile from the small intestine into the stomach and esophagus, may be managed with UDCA.
  • Promising emerging evidence suggests that bile acid treatment may help manage inflammation associated with psoriasis.
  • CA is approved for supporting health in rare bile acid synthesis disorders (13, 14).
  • A growing body of evidence supports the potential benefits of tauroursodeoxycholic acid (TUDCA) in supporting fat digestion, microbiome diversity, reduction of cellular stress, liver health, and neurological well-being.

Summary

Bile acids support fat digestion, stimulate bile flow, and enhance cholesterol elimination. Imbalances in bile acid synthesis and metabolism may be associated with fat malabsorption, nutrient deficiencies, and metabolic concerns. Blood and stool tests can evaluate bile acid levels and ratios to help determine underlying causes of digestive and metabolic symptoms. Addressing diet and the microbiome can support healthy bile acid levels. Emerging evidence supports a wide range of potential uses for bile acids/salts. Working with a functional medicine doctor, you can learn how bile acids may affect your health and if you are a good candidate for bile acid supplementation.

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

1. Staels, B., & Fonseca, V. (2009). Bile Acids and Metabolic Regulation. Diabetes Care, 32(suppl_2), S237–S245. https://doi.org/10.2337/dc09-s355

2. Hofmann, A.F. The Continuing Importance of Bile Acids in Liver and Intestinal Disease. Arch Intern Med. 1999;159(22):2647–2658. doi:10.1001/archinte.159.22.2647

3. Wang, D., Cohen, D., & Carey, M.C. (2009). Biliary lipids and cholesterol gallstone disease. Journal of Lipid Research, 50, S406–S411. https://doi.org/10.1194/jlr.r800075-jlr200

4. Wang, H.H., Portincasa, P., & Wang, D. (2008). Molecular pathophysiology and physical chemistry of cholesterol gallstones. Frontiers in Bioscience, 13(13), 401. https://doi.org/10.2741/2688

5. Kakiyama, G., Hylemon, P.B., Zhou, H., et al. (2014). Colonic inflammation and secondary bile acids in alcoholic cirrhosis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 306(11), G929–G937. https://doi.org/10.1152/ajpgi.00315.2013

6. Ridlon, J.M., Alves, J., Hylemon, P.B., et al. (2013). Cirrhosis, bile acids and gut microbiota. Gut Microbes, 4(5), 382–387. https://doi.org/10.4161/gmic.25723

7. Nguyen, T.H.O., Ung, T.T., Kim, N., et al. (2018). Role of bile acids in colon carcinogenesis. World Journal of Clinical Cases, 6(13), 577–588. https://doi.org/10.12998/wjcc.v6.i13.577

8. Novel approaches to the diagnosis of bile acid diarrhea - Mayo Clinic. (2020, April 23). https://www.mayoclinic.org/medical-professionals/digestive-diseases/news/novel-approaches-to-the-diagnosis-of-bile-acid-diarrhea/mqc-20479822

9. Ajouz, H., Mukherji, D., & Shamseddine, A. (2014). Secondary bile acids: an underrecognized cause of colon cancer. World Journal of Surgical Oncology, 12(1). https://doi.org/10.1186/1477-7819-12-164

10. Van Munster, I.P., & Nagengast, F.M. (1993). The Role of Carbohydrate Fermentation in Colon Cancer Prevention. Scandinavian Journal of Gastroenterology, 28(sup200), 80–86. https://doi.org/10.3109/00365529309101581

11. Fromm, H. (1986). Gallstone dissolution therapy. Gastroenterology, 91(6), 1560–1567. https://doi.org/10.1016/0016-5085(86)90216-7

12. Achufusi, T.G.O, Safadi, A.O, & Mahabadi, N. (2022). Megaloblastic Anemia. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK545303/

13. FDA approves Cholbam to treat rare bile acid synthesis disorders. (2015, March 18). Fierce Biotech. https://www.fiercebiotech.com/biotech/fda-approves-cholbam-to-treat-rare-bile-acid-synthesis-disorders

14. National Organization for Rare Disorders. (2023, January 12). Bile Acid Synthesis Disorders - Symptoms, Causes, Treatment. https://rarediseases.org/rare-diseases/bile-acid-synthesis-disorders/

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Running Your Business
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.